Levels of sEPCR decline in patients beginning warfarin treatment.

Levels of sEPCR (A) and F1 + 2 (B) were determined in 7 patients before the start of oral anticoagulant therapy (time 0) and during treatment. The diagnoses for the patients were atrial fibrillation (AF), dilative cardiomyopathy (Dil Cardiom), mitral valve disease (MVD), and deep vein thrombosis (DVT).